IMUX Immunic, Inc.
$11.42▼ -3.55%
Healthcare
Other
After hours
$11.25▼ -1.49%
Sep 11, 7:30 PM ET
Volume 332.7K
Avg Volume (10D) 341.5K
Key Metrics & Fundamentals
Market Cap
$155.82M
P/E Ratio
–
Div Yield
–%
52W Range
5.06 - 17.43
% vs 50 MA
-19.93%
% vs 200 MA
6.67%
RSI-14
28.8
MACD Histogram
-0.5000
Beta (1Y vs SPY)
1.51
Free Cash Flow
-$31.25M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$35.29M
COGS
–
Operating Exp
$35.33M
Operating Income
-$35.33M
EBIT
-$35.33M
Pretax Income
-$34.10M
Net Income
-$34.10M
EPS (Diluted)
-0.80
Price & Volume History
Loading chart…
Recent News
Immunic to host virtual relapsing MS R&D Day on September 9
Proactive · Sep 2, 2026 12:40 PM
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
PR Newswire · Sep 2, 2026 10:30 AM
Immunic appoints Chitrang Davé as chief data and digital officer
Proactive · Sep 1, 2026 12:36 PM
Can Immunic (IMUX) Climb 163.03% to Reach the Level Wall Street Analysts Expect?
Zacks · Aug 13, 2026 1:55 PM
Immunic advances MS drug toward key Phase 3 data, expects results by year-end
Proactive · Aug 11, 2026 12:36 PM
Immunic: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 10:34 AM
Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire · Aug 11, 2026 10:30 AM
Immunic appoints Elena Ridloff to board of directors
Proactive · Aug 10, 2026 8:36 PM
Immunic CEO on Q2 progress and Phase 3 MS trial milestones
Proactive · Aug 10, 2026 7:07 PM
Immunic to Participate in Investor Conferences in July
PR Newswire · Jul 9, 2026 10:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See IMUX's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.